K-ras Mutation in Lung Cancer
Author Information
Author(s): M Sagawa, Y Saito, S Fujimura, RI Linnoila
Primary Institution: National Cancer Institute
Hypothesis
The K-ras mutation occurs in the early stage of carcinogenesis in lung cancer.
Conclusion
The study found that K-ras mutations are present in early preneoplastic lesions and are homogeneous in lung carcinoma tissues.
Supporting Evidence
- 14 out of 61 samples had a mutation in the K-ras codon 12.
- 12 out of 41 adenocarcinomas had a mutation.
- All carcinoma tissues examined had the K-ras mutation.
Takeaway
Scientists looked at lung cancer samples and found a common mutation that happens early in the disease, which helps us understand how lung cancer starts.
Methodology
The study used selective ultraviolet radiation fractionation and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to analyze lung carcinoma tissues.
Limitations
The study had a limited number of preneoplastic lesions and did not detect mutations in all types of lesions.
Want to read the original?
Access the complete publication on the publisher's website